Journal article
Novel molecular targets for hepatocellular carcinoma
IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli1
T-Cells and Cancer, Experimental & Translational Immunology, Department of Health Technology, Technical University of Denmark2
Experimental & Translational Immunology, Department of Health Technology, Technical University of Denmark3
Department of Health Technology, Technical University of Denmark4
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer globally. Indeed, only a few treatments are available, most of which are effective only for the early stages of the disease. Therefore, there is an urgent needing for potential markers for a specifically targeted therapy.
Candidate proteins were selected from datasets of The Human Protein Atlas, in order to identify specific tumor-associated proteins overexpressed in HCC samples associated with poor prognosis. Potential epitopes were predicted from such proteins, and homology with peptides derived from viral proteins was assessed.
A multiparametric validation was performed, including recognition by PBMCs from HCC-patients and healthy donors, showing a T-cell cross-reactivity with paired epitopes. These results provide novel HCC-specific tumor-associated antigens (TAAs) for immunotherapeutic anti-HCC strategies potentially able to expand pre-existing virus-specific CD8+ T cells with superior anticancer efficacy.
Language: | English |
---|---|
Publisher: | MDPI |
Year: | 2022 |
Pages: | 140 |
ISSN: | 20726694 |
Types: | Journal article |
DOI: | 10.3390/cancers14010140 |
ORCIDs: | Hadrup, Sine Reker , 0000-0002-3254-0322 and 0000-0002-3523-3264 |